138 related articles for article (PubMed ID: 37685746)
1. Clinical Link between the BARD Score at Diagnosis and Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Lee TG; Park PG; Park YB; Huh JH; Lee SW
J Clin Med; 2023 Aug; 12(17):. PubMed ID: 37685746
[TBL] [Abstract][Full Text] [Related]
2. Non-alcoholic fatty liver disease fibrosis score is a useful index for predicting all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Whang JY; Park PG; Park YB; Huh JH; Lee SW
Front Med (Lausanne); 2023; 10():1217937. PubMed ID: 37711740
[TBL] [Abstract][Full Text] [Related]
3. Male Sex Is a Significant Predictor of All-cause Mortality in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Kwon HC; Pyo JY; Lee LE; Ahn SS; Song JJ; Park YB; Lee SW
J Korean Med Sci; 2021 May; 36(18):e120. PubMed ID: 33975396
[TBL] [Abstract][Full Text] [Related]
4. Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index at Diagnosis Is Associated with All-Cause Mortality during Follow-Up in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Cho M; Rah W; Song JJ; Park YB; Lee SW
Medicina (Kaunas); 2024 Feb; 60(3):. PubMed ID: 38541107
[No Abstract] [Full Text] [Related]
5. Systemic immune-inflammation index could estimate the cross-sectional high activity and the poor outcomes in immunosuppressive drug-naïve patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Kim Y; Choi H; Jung SM; Song JJ; Park YB; Lee SW
Nephrology (Carlton); 2019 Jul; 24(7):711-717. PubMed ID: 30203901
[TBL] [Abstract][Full Text] [Related]
6. New index using triglyceride glucose-body mass index for predicting mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Park PG; Pyo JY; Ahn SS; Song JJ; Park YB; Huh JH; Lee SW
Front Med (Lausanne); 2023; 10():1168016. PubMed ID: 37275374
[TBL] [Abstract][Full Text] [Related]
7. Triglyceride and Glucose Index Predicts Acute Coronary Syndrome in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Park PG; Pyo JY; Ahn SS; Song JJ; Park YB; Huh JH; Lee SW
Diagnostics (Basel); 2022 Jun; 12(6):. PubMed ID: 35741296
[TBL] [Abstract][Full Text] [Related]
8. Total Globulin Fraction at Diagnosis Could Forecast All-Cause Mortality during the Disease Course in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Ha JW; Ahn SS; Song JJ; Park YB; Lee SW
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373863
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen to albumin ratio reflects the activity of antineutrophil cytoplasmic antibody-associated vasculitis.
Lee LE; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
J Clin Lab Anal; 2021 Apr; 35(4):e23731. PubMed ID: 33591581
[TBL] [Abstract][Full Text] [Related]
10. Serum glycated albumin as a predictive biomarker for renal involvement of antineutrophil cytoplasmic antibody-associated vasculitis in non-diabetic patients.
Park PG; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
BMC Nephrol; 2022 Aug; 23(1):288. PubMed ID: 35982401
[TBL] [Abstract][Full Text] [Related]
11. Controlling Nutritional Status Score is Associated with All-Cause Mortality in Patients with Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Yonsei Med J; 2019 Dec; 60(12):1164-1173. PubMed ID: 31769247
[TBL] [Abstract][Full Text] [Related]
12. Fatty Liver Index Independently Predicts All-Cause Mortality in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis but No Substantial Liver Disease.
Park PG; Pyo JY; Ahn SS; Choi HJ; Song JJ; Park YB; Huh JH; Lee SW
Front Cardiovasc Med; 2022; 9():848121. PubMed ID: 35811721
[TBL] [Abstract][Full Text] [Related]
13. Effect of numbers of metabolic syndrome components on mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis with metabolic syndrome.
Park PG; Pyo JY; Ahn SS; Song JJ; Park YB; Huh JH; Lee SW
Clin Exp Rheumatol; 2022 May; 40(4):758-764. PubMed ID: 35200129
[TBL] [Abstract][Full Text] [Related]
14. Systemic inflammation response index predicts all-cause mortality in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Lee LE; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
Int Urol Nephrol; 2021 Aug; 53(8):1631-1638. PubMed ID: 33428165
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population.
Rigor J; Diegues A; Presa J; Barata P; Martins-Mendes D
Postgrad Med; 2022 May; 134(4):435-440. PubMed ID: 35332833
[TBL] [Abstract][Full Text] [Related]
16. Double positivity for antineutrophil cytoplasmic antibody (ANCA) and anti-glomerular basement membrane antibody could predict end-stage renal disease in ANCA-associated vasculitis: a monocentric pilot study.
Yoo BW; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
Clin Rheumatol; 2020 Mar; 39(3):831-840. PubMed ID: 31802348
[TBL] [Abstract][Full Text] [Related]
17. Increased prevalence rate of metabolic syndrome is an independent predictor of cardiovascular disease in patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Lee SB; Kwon HC; Kang MI; Park YB; Park JY; Lee SW
Rheumatol Int; 2022 Feb; 42(2):291-302. PubMed ID: 34086074
[TBL] [Abstract][Full Text] [Related]
18. Nutrition Risk Index Score at Diagnosis Can Effectively Predict Poor Prognosis in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
Ha JW; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
J Ren Nutr; 2022 Jul; 32(4):423-431. PubMed ID: 34294554
[TBL] [Abstract][Full Text] [Related]
19. Modified Body Mass Index at Diagnosis is a Useful Predictor of Mortality in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis.
Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
J Rheum Dis; 2022 Jul; 29(3):154-161. PubMed ID: 37475972
[TBL] [Abstract][Full Text] [Related]
20. Clinical features of Korean elderly patients with antineutrophil cytoplasmic antibody-associated vasculitis.
Yoo BW; Song JJ; Park YB; Lee SW
Korean J Intern Med; 2021 May; 36(3):731-741. PubMed ID: 32811130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
